M. Shullo

4.2k total citations
52 papers, 920 citations indexed

About

M. Shullo is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Shullo has authored 52 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 23 papers in Transplantation and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Shullo's work include Transplantation: Methods and Outcomes (29 papers), Renal Transplantation Outcomes and Treatments (23 papers) and Mechanical Circulatory Support Devices (11 papers). M. Shullo is often cited by papers focused on Transplantation: Methods and Outcomes (29 papers), Renal Transplantation Outcomes and Treatments (23 papers) and Mechanical Circulatory Support Devices (11 papers). M. Shullo collaborates with scholars based in United States, Canada and United Kingdom. M. Shullo's co-authors include C. Bermúdez, Robert L. Kormos, J.J. Teuteberg, Dennis M. McNamara, Adriana Zeevi, Jeffrey J. Teuteberg, John G. Lunz, Steven A. Webber, Brian Feingold and Christopher R. Ensor and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

M. Shullo

49 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Shullo United States	19	639	406	245	236	159	52	920
Clément Gosset France	12	482 0.8×	397 1.0×	48 0.2×	102 0.4×	226 1.4×	22	888
Diana Zaldonis United States	22	1.1k 1.7×	527 1.3×	509 2.1×	74 0.3×	373 2.3×	51	1.6k
Gaia Magnani Italy	17	430 0.7×	212 0.5×	115 0.5×	391 1.7×	192 1.2×	47	856
Stacy F. Davis United States	14	536 0.8×	115 0.3×	219 0.9×	608 2.6×	81 0.5×	29	1.1k
Rebecca R. Goff United States	10	599 0.9×	254 0.6×	265 1.1×	58 0.2×	63 0.4×	16	741
J. Parameshwar United Kingdom	13	367 0.6×	108 0.3×	184 0.8×	156 0.7×	121 0.8×	36	689
Ana M Guerreiro Hernández Spain	16	334 0.5×	336 0.8×	38 0.2×	49 0.2×	125 0.8×	64	895
Per Wierup United States	20	1.0k 1.6×	150 0.4×	437 1.8×	618 2.6×	263 1.7×	100	1.5k
Amanda K. Davis Australia	14	294 0.5×	41 0.1×	330 1.3×	205 0.9×	67 0.4×	31	925
Phillip C. Camp United States	16	561 0.9×	259 0.6×	158 0.6×	167 0.7×	132 0.8×	35	901

Countries citing papers authored by M. Shullo

Since Specialization

Citations

This map shows the geographic impact of M. Shullo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Shullo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Shullo more than expected).

Fields of papers citing papers by M. Shullo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Shullo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Shullo. The network helps show where M. Shullo may publish in the future.

Co-authorship network of co-authors of M. Shullo

This figure shows the co-authorship network connecting the top 25 collaborators of M. Shullo. A scholar is included among the top collaborators of M. Shullo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Shullo. M. Shullo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, J. Bernadette, et al.. (2025). Treatment Failure of Sofosbuvir/Velpatasvir for Donor-Derived Hepatitis C Genotype 3. The Journal of Heart and Lung Transplantation. 44(4). S300–S300.

Xu, Qingyong, M. Shullo, Massimo Mangiola, et al.. (2021). Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates. The Journal of Heart and Lung Transplantation. 40(7). 595–603. 18 indexed citations

Moayedi, Yasbanoo, Carlos A. Gómez, Chun‐Po Steve Fan, et al.. (2019). Infectious complications after heart transplantation in patients screened with gene expression profiling. The Journal of Heart and Lung Transplantation. 38(6). 611–618. 6 indexed citations

Teuteberg, Jeffrey, et al.. (2019). Thrombotic events with proliferation signal inhibitor‒based immunosuppression in cardiac transplantation. The Journal of Heart and Lung Transplantation. 38(6). 619–626. 4 indexed citations

Lange, Nicholas W., William L. Baker, M. Shullo, et al.. (2018). Outcomes Associated With Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-analysis. The Journal of Heart and Lung Transplantation. 37(4). S90–S91. 1 indexed citations

Moayedi, Yasbanoo, Farid Foroutan, Robert J.H. Miller, et al.. (2018). Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients. The Journal of Heart and Lung Transplantation. 38(1). 51–58. 31 indexed citations

Althouse, Andrew D., et al.. (2018). Substantial Reduction in Driveline Infection Rates With the Modification of Driveline Dressing Protocol. Journal of Cardiac Failure. 24(11). 746–752. 14 indexed citations

Jennings, Douglas L., Nicholas W. Lange, M. Shullo, et al.. (2018). Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis. International Journal of Cardiology. 265. 71–76. 30 indexed citations

Rivosecchi, Ryan, Cornelius J. Clancy, Ryan K. Shields, et al.. (2017). Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. Antimicrobial Agents and Chemotherapy. 61(9). 40 indexed citations

10.

Shullo, M., et al.. (2014). Cancer-Free Survival Following Alemtuzumab Induction in Heart Transplantation. Transplantation Proceedings. 46(5). 1481–1488. 3 indexed citations

11.

Lampert, Brent C., Chad E. Eckert, Stephanie Weaver, et al.. (2013). Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events. The Annals of Thoracic Surgery. 97(1). 139–146. 61 indexed citations

12.

Zeevi, Adriana, John G. Lunz, Brian Feingold, et al.. (2012). Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. The Journal of Heart and Lung Transplantation. 32(1). 98–105. 151 indexed citations

13.

Ensor, Christopher R., et al.. (2011). Generic Maintenance Immunosuppression in Solid Organ Transplant Recipients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(11). 1111–1129. 40 indexed citations

14.

Shullo, M., Robert L. Kormos, K.L. Lockard, et al.. (2011). Impact of Renal Function Before Mechanical Circulatory Support on Posttransplant Renal Outcomes. The Annals of Thoracic Surgery. 91(5). 1348–1354. 43 indexed citations

15.

Khandhar, Sameer, M. Shullo, R. Zomak, et al.. (2011). Long‐term effects on renal function of dose‐reduced calcineurin inhibitor and sirolimus in cardiac transplant patients. Clinical Transplantation. 26(1). 42–49. 6 indexed citations

16.

Shullo, M., Kristine S. Schonder, & J.J. Teuteberg. (2010). Elevated Tacrolimus Levels Associated With Intravenous Azithromycin and Ceftriaxone: A Case Report. Transplantation Proceedings. 42(5). 1870–1872. 12 indexed citations

17.

Teuteberg, J.J., M. Shullo, R. Zomak, et al.. (2009). Alemtuzumab Induction Prior to Cardiac Transplantation with Lower Intensity Maintenance Immunosuppression: One-Year Outcomes. American Journal of Transplantation. 10(2). 382–388. 35 indexed citations

18.

Teuteberg, J.J., M. Shullo, R. Zomak, et al.. (2008). Aggressive steroid weaning after cardiac transplantation is possible without the additional risk of significant rejection. Clinical Transplantation. 22(6). 730–737. 22 indexed citations

19.

Shullo, M., et al.. (2002). Limited Tolerability of Levofloxacin and Pyrazinamide for Multidrug‐Resistant Tuberculosis Prophylaxis in a Solid Organ Transplant Population. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(6). 701–704. 30 indexed citations

20.

Shullo, M., Carlos Vivas, Mark L. Jordan, et al.. (2002). Hemorrhagic Complications of Enoxaparin and Aspirin in Patients with Kidney Transplants. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(2). 184–187. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact